Blood transfusion is an essential part of modern health care. Used correctly, it can save lives and improve health. However, inappropriate and improper use of blood can lead to adverse reactions resulting in morbidity and even mortality. Safety of blood and blood products is of serious concern to countries, officials in charge of Blood Transfusion Services and prescribing clinicians. Apart from the well-known transfusion transmissible infections like HIV and hepatitis viruses, there are many emerging and re-emerging infections which are transmitted or could potentially be transmitted through blood transfusion. In keeping with the WHO recommendations, Mauritius is required to have an approved National Blood Policy and a strategic framework that will ensure an adequate supply of safe and effective blood products and related medical services that are used appropriately for the benefit of all patients in Mauritius.
In this context, Dr Jean Baptiste Tapko, WHO-consultant and expert on Blood and Blood products undertook a mission from 31st July to 10th August 2018 to review and finalize the National Blood Policy in Mauritius and support the country in developing a Strategic Framework for Action as well as finalize the Standards. The mission started with briefing meeting between. Dr Hon Anwar Husnoo, Minister of Health and Quality of life, Dr. Laurent Musango, WHO Representative in Mauritius and key policy makers at the Health Ministry. During the meeting the objectives of the mission were discussed and orientation from the Minister was provided to the team working on National Blood policy.
